Rafael Caparica

8PUBLICATIONS
51CO-AUTHORS
Molecular targetsChemotherapyEnvironmental epidemiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.

Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro

|Dec 01, 2023
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.

Daniel S W Tan, Enriqueta Felip, Gilberto de Castro

|Nov 08, 2023
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.

Diogo Martins-Branco, Marie Kassapian, Véronique Debien

|Sep 01, 2022
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.

Guilherme Nader-Marta, Véronique Debien, Daniel Eiger

|Mar 03, 2021
Effectiveness and toxicity of adjuvant chemotherapy in patients with non-small cell lung cancer.

Guilherme Harada, Maria Fernanda Batistuzzo Vicentini Neffa, Renata Colombo Bonadio

|Dec 18, 2020
Malignant bowel obstruction: effectiveness and safety of systemic chemotherapy.

Rafael Caparica, Larissa Amorim, Paulo Amaral

Pageof 2

Frequent Collaborators

3 joint publications

Gilberto De Castro

2 joint publications

Marina Chiara Garassino

2 joint publications

Jan C Brase

2 joint publications

Benjamin J Solomon